Dennis Berman
Vermögen: 44 910 $ am 30.09.2026
Vermögen: 44 910 $ am 30.09.2026
Mr. Dennis N.
Berman is a President at Molino Ventures LLC.
Mr. Berman was previously employed as an Independent Director by Inhibikase Therapeutics, Inc., a Director & EVP-Corporate Development by Tocagen, Inc., a Vice President-Corporate Development by InterVU, Inc., a Partner by Sonnenschein Nath & Rosenthal LLP, a Partner by Norton Rose Germany LLP, and an Executive Vice President by Kintera, Inc. He also served on the board at Chiron Viagene, Inc. He received his undergraduate degree from the University of Pennsylvania, an undergraduate degree from The Wharton School of the University of Pennsylvania and a graduate degree from Harvard Law School.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.07.2026 | 21.854 ( 0,02 % ) | 44 910 $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
Molino Ventures LLC | Präsident | 01.06.2017 |
| Unternehmen | Position | Ende |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 19.10.2026 |
| FORTE BIOSCIENCES | Gründer | 15.04.2017 |
InterVU, Inc.
InterVU, Inc. Information Technology ServicesTechnology Services Provides Internet video delivery products | Corporate Officer/Principal | 01.01.2000 |
Sonnenschein Nath & Rosenthal LLP
Sonnenschein Nath & Rosenthal LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01.07.1999 |
Norton Rose Fulbright (Germany) LLP
Norton Rose Fulbright (Germany) LLP Miscellaneous Commercial ServicesCommercial Services Provides corporate and financial law services | Corporate Officer/Principal | 01.01.1985 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 11 |
|---|---|
InterVU, Inc.
InterVU, Inc. Information Technology ServicesTechnology Services Provides Internet video delivery products | Technology Services |
Tocagen, Inc.
Tocagen, Inc. BiotechnologyHealth Technology Develops biopharmaceutical drugs | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kintera, Inc.
Kintera, Inc. Packaged SoftwareTechnology Services Provides Internet fund raising and communication software solutions | Technology Services |
Chiron Viagene, Inc.
Chiron Viagene, Inc. Miscellaneous Commercial ServicesCommercial Services Commercial biotechnical research | Commercial Services |
Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Law School
Harvard Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sonnenschein Nath & Rosenthal LLP
Sonnenschein Nath & Rosenthal LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Norton Rose Fulbright (Germany) LLP
Norton Rose Fulbright (Germany) LLP Miscellaneous Commercial ServicesCommercial Services Provides corporate and financial law services | Commercial Services |
Molino Ventures LLC |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen